欧洲人工泪液市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(纤维素衍生泪液、甘油衍生泪液、油基乳液泪液、聚乙二醇基泪液、丙二醇基泪液和透明质酸钠基人工泪液);给药方式(滴眼剂和药膏);应用(干眼症治疗、隐形眼镜保湿)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 131    |    Report Code: TIPRE00023487    |    Category: Life Sciences

Europe Artificial Tears Market

市场介绍

人工泪液是润滑性滴眼液,用于治疗因干眼症或泪液分泌不足引起的刺激和干燥。干燥性角结膜炎。它们还用于湿润隐形眼镜以及在眼部检查和检查期间。快速增长的老龄化人口主要促进了人工泪液市场的增长。衰老使人们更容易患干眼症等眼部疾病,从而导致对人工泪液的高需求。此外,眼科手术和眼科手术后管理数量的增加进一步推动了人工泪液市场的增长。

因此,日益增长的老年人口预计将在未来几年对人工泪液产生巨大需求,预计这将进一步推动人工泪液市场的发展。

更多时间在室内开着中央暖气以及长时间盯着屏幕被认为是导致干眼症增加的因素COVID-19 大流行中的综合症。根据研究,英国四分之一的人(约 1300 万成年人)患有干眼症,这种疾病会导致眼睛发红、发痒和疲劳。眼睛疲劳是另一种眼睛问题,随着盯着屏幕的时间增加,这种问题变得更加普遍,可能会加剧这些症状。过多的屏幕时间或未能让眼睛定期休息是两个主要原因 - 只需查看一些统计数据即可了解“虚拟生活”的压力如何影响眼睛。研究显示,英国成年人在封锁期间购买了多达 2100 万台新数字设备,包括电视、游戏机和笔记本电脑,Zen Internet 的另一项研究发现,英国的互联网使用量同比猛增 78%。 2020.其他已知的干眼原因包括长时间接触空调或暖气、长期佩戴隐形眼镜以及某些药物的副作用。激素异常也可能是有道理的。经历围绝经期和更年期的女性可能会发现她们的眼睛变得干燥,这与雌激素水平下降引起的荷尔蒙变化有关。这些因素对欧洲人工泪液市场产生潜在影响。

 

市场概况与动态

欧洲人工泪液市场预计将从2021年的5.46亿美元增长到2028年的8.169亿美元;据估计,从 2021 年到 2028 年,干眼症的复合年增长率为 5.9%。干眼症的发病率在人口中不断上升,尤其是在发达国家。干眼症是由多种因素引起的,会导致不适、刺激和视力障碍。此外,老年人的患病率为 18.6%。从性别来看,女性的患病率较高;男性占8.8%,男性占4.5%。欧洲地区人群的干眼发病率较高。人工泪液可滋润眼睛并缓解干眼症。因此,干眼症患病率的日益增加预计将推动人工泪液市场的发展。

 

主要细分市场

从类型来看,甘油衍生泪液细分市场在2020年欧洲人工泪液市场中占据最大份额。从输送方式来看,滴眼液细分市场在欧洲人工泪液市场中占据最大份额。 2020年人工泪液市场。从应用来看,2020年人工泪液市场中,干眼治疗领域占据较大市场份额。

 

主要来源和上市公司

准备本人工合成报告时参考的一些主要一手和二手来源欧洲的眼泪市场包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Johnson and Johnson Services, Inc.

Alcon Inc.

OASIS Medical

AbbVie Inc.

拜耳公司

Prestige Consumer Healthcare Inc.

参天制药有限公司和

Bausch Health Companies Inc. p>

 

购买报告的理由

  • 了解欧洲人工泪液市场格局并确定最有可能的细分市场确保丰厚的回报
  • 了解欧洲人工泪液市场不断变化的竞争格局,保持领先地位
  • 有效规划欧洲人工泪液市场的并购和合作交易通过识别最有希望销售的细分市场
  • 通过对欧洲人工泪液市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得市场收入预测2021-2028 年欧洲地区各个细分市场

 

欧洲人工泪液市场细分

类型

  • < span>甘油衍生眼泪
  • 纤维素衍生眼泪
  • 油基乳液眼泪
  • < li>聚乙二醇泪液
  • 透明质酸钠人工泪液
  • 丙二醇泪液

 

投放方式

  • 眼药水
  • 软膏

 

 

按应用

  • 干眼症治疗
  • 隐形眼镜水分

 

按国家/地区

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区

 

提及的公司

  1. 强生服务公司
  2. 爱尔康公司
  3. OASIS Medical
  4. 艾伯维公司
  5. 拜耳公司
  6. 拜耳公司
  7. 艾伯维公司
  8. 拜耳公司
  9. li>
  10. Prestige Consumer Healthcare Inc.
  11. 参天制药有限公司
  12. Bausch Health Companies Inc.

 < /p>

 

 

Europe Artificial Tears Strategic Insights

Strategic insights for Europe Artificial Tears involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-artificial-tears-market-strategic-framework.webp
Get more information on this report

Europe Artificial Tears Report Scope

Report Attribute Details
Market size in 2021 US$ 546.0 Million
Market Size by 2028 US$ 816.9 Million
Global CAGR (2021 - 2028) 5.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 类型
  • 纤维素泪液
  • 甘油泪液
  • 油性乳剂泪液
  • 聚乙二醇泪液
  • 丙二醇泪液
  • 透明质酸钠人工泪液
By 给药方式
  • 眼药水
  • 药膏
By 应用
  • 干眼症治疗
  • 隐形眼镜保湿
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Johnson and Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Get more information on this report

    Europe Artificial Tears Regional Insights

    The regional scope of Europe Artificial Tears refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-artificial-tears-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Artificial Tears Market

    1. Johnson and Johnson Services, Inc.
    2. Alcon Inc.
    3. OASIS Medical
    4. AbbVie Inc.
    5. Bayer AG
    6. Prestige Consumer Healthcare Inc.
    7. Santen Pharmaceutical Co., Ltd.
    8. Bausch Health Companies Inc.
    Frequently Asked Questions
    How big is the Europe Artificial Tears Market?

    The Europe Artificial Tears Market is valued at US$ 546.0 Million in 2021, it is projected to reach US$ 816.9 Million by 2028.

    What is the CAGR for Europe Artificial Tears Market by (2021 - 2028)?

    As per our report Europe Artificial Tears Market, the market size is valued at US$ 546.0 Million in 2021, projecting it to reach US$ 816.9 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.

    What segments are covered in this report?

    The Europe Artificial Tears Market report typically cover these key segments-

  • 类型 (纤维素泪液, 甘油泪液, 油性乳剂泪液, 聚乙二醇泪液, 丙二醇泪液, 透明质酸钠人工泪液)
  • 给药方式 (眼药水, 药膏)
  • 应用 (干眼症治疗, 隐形眼镜保湿)
  • What is the historic period, base year, and forecast period taken for Europe Artificial Tears Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Artificial Tears Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Artificial Tears Market?

    The Europe Artificial Tears Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Johnson and Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Who should buy this report?

    The Europe Artificial Tears Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Artificial Tears Market value chain can benefit from the information contained in a comprehensive market report.